Step 6: Inspect the solution
I would be interested to see further research in this area. With acknowledged benefits for people with diabetes, having first been approved for use in 2005, GLP-1 drugs for weight loss may re-position overweight and obesity in a clearly medical context, with the potential of reducing the historical stigma associated with these conditions
Wu Y, Wei M, Wang M, Guo M, Yu H, Chen Y, et al
How Fast Can I Bring My GGT Levels Down
The order below moves from the most common and benign effects to the most situation-specific: gastrointestinal tolerability first, then the odor effect, then the debated TMAO cardiovascular signal, and finally route- and form-specific considerations
In clinical practice, GLP-1 RAs are not a universal solution